Fanucci Marsha

CIK 00012988148 companiesSOMERVILLE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001298814

Recent Transactions

50 trades

Award
Generate Biomedicines, Inc.$GENB
Stock Option (Right to Buy)
2026-02-26+29,561→ 29,561 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2024-06-05+6,000→ 6,000 total
Award
Syros Pharmaceuticals, Inc.
Common Stock
2024-06-05+4,000→ 16,000 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-01+6,000→ 6,000 total
Award
Syros Pharmaceuticals, Inc.
Common Stock
2023-06-01+4,000→ 12,000 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2023-05-18+3,454→ 3,454 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2023-02-23+136→ 136 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Restricted Stock Units
2023-02-23−136→ 0 total
Disposition from Tender
Forma Therapeutics Holdings, Inc.
Common Stock
2022-10-14−52,532→ 0 total
Disposition to Issuer
Forma Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2022-10-14−28,053→ 0 total
Disposition to Issuer
Forma Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2022-10-14−8,375→ 0 total
Disposition to Issuer
Forma Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2022-10-14−6,750→ 0 total
Disposition from Tender
Forma Therapeutics Holdings, Inc.
Common Stock
2022-10-14−7,250→ 0 total
Disposition to Issuer
Forma Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2022-10-14−14,026→ 0 total
Disposition to Issuer
Forma Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2022-10-14−17,533→ 0 total
Award
Syros Pharmaceuticals, Inc.
Common Stock
2022-09-16+8,000→ 8,000 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2022-09-16+12,000→ 12,000 total
Award
Cyclerion Therapeutics, Inc.$CYCN
Stock Option (Right to Buy)
2022-06-14+20,000→ 20,000 total
Award
Forma Therapeutics Holdings, Inc.
Common Stock
2022-06-08+4,500→ 59,782 total
Award
Forma Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2022-06-08+6,750→ 6,750 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2022-06-01+17,500→ 17,500 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2022-05-18+5,153→ 5,153 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Restricted Stock Units
2022-02-23+136→ 136 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2021-07-15+4,032→ 4,032 total
Award
Cyclerion Therapeutics, Inc.$CYCN
Stock Option (Right to Buy)
2021-06-24+10,000→ 10,000 total
Award
Forma Therapeutics Holdings, Inc.
Common Stock
2021-06-17+2,750→ 55,282 total
Award
Forma Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2021-06-17+8,375→ 8,375 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2021-06-08+17,500→ 17,500 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2020-07-01+4,581→ 4,581 total
Sale
Forma Therapeutics Holdings, Inc.
Enterprise 3 Junior Stock
2020-06-23−9,847→ 0 total
Purchase
Forma Therapeutics Holdings, Inc.
Common Stock
2020-06-23+52,532→ 52,532 total
Sale
Forma Therapeutics Holdings, Inc.
Enterprise 2 Junior Stock
2020-06-23−33,781→ 0 total
Sale
Forma Therapeutics Holdings, Inc.
Enterprise 5 Junior Stock
2020-06-23−14,026→ 0 total
Sale
Forma Therapeutics Holdings, Inc.
Enterprise 4 Junior Stock
2020-06-23−10,240→ 0 total
Award
Forma Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2020-06-18+17,533→ 0 total
Award
Cyclerion Therapeutics, Inc.$CYCN
Stock Option (Right to Buy)
2020-06-16+10,000→ 10,000 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2020-06-11+17,500→ 17,500 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2019-11-20$100.00/sh−75,000→ 0 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2019-11-20−15,000→ 0 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Non-Qualified Stock Option (right to buy)
2019-11-20−15,000→ 0 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2019-11-20$9.30/sh+15,000→ 45,000 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2019-11-20$11.33/sh+15,000→ 60,000 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2019-11-20−15,000→ 0 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2019-11-20$9.14/sh+30,000→ 30,000 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2019-11-20$30.09/sh+15,000→ 75,000 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Non-Qualified Stock Option (right to buy)
2019-11-20−30,000→ 0 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2019-07-01+9,000→ 9,000 total
Award
Syros Pharmaceuticals, Inc.
Common Stock (right to buy)
2019-06-11+11,000→ 11,000 total
Award
Cyclerion Therapeutics, Inc.$CYCN
Stock Option (Right to Buy)
2019-06-01+10,000→ 10,000 total
Disposition to Issuer
IRONWOOD PHARMACEUTICALS INC$IRWD
Class A Common Stock
2019-04-01−4,056→ 132,663 total

Companies

Recent Filings

Address

GENERATE BIOMEDICINES, INC. 101 SOUTH STREET, SUITE 900

SOMERVILLE, MA, 02143

View on SEC.gov